Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Month: October 2022
Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages
– Data to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting…
Fountain Therapeutics Congratulates Co-Founder and Executive Chairman Thomas Rando, M.D., Ph.D., for Prestigious NOMIS Distinguished Scientist Award
Ceremony Held Today in Zurich, Switzerland with Presentation by Dr. Rando and Keynote by Nobel…
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
PDS Biotech Announces Abstracts Involving Research of PDS0101 Accepted for Presentation at SITC 2022
Abstracts highlight data from Phase 2 clinical trials – PDS0101-CRT combination study in cervical cancer…
Nurix Therapeutics Announces Six Poster Presentations at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage…
Pliant Therapeutics to Participate in the RBC Biotech Expert Insights Series: Pulmonary/Lung Disease Mini-Symposium
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Immutep Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
Initial data from INSIGHT-003 trial treating patients with various solid tumours with triple combination therapy…
Arch Biopartners Adds Farris Smith as a Strategic Advisor
TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) — Today, Arch Biopartners Inc., (“Arch” or the “Company”)…
Mindset Pharma Selects Lead Clinical Candidates From “Family 2” of its Next Generation Psychedelic Drug Portfolio
MSP-2020 and MSP-2003, exhibiting a stronger and shorter acting psychedelic effect than psilocybin in preclinical…
Syneos Health Releases Annual Sustainability Report
Report Spotlights Significant Progress Toward Achieving Company’s Environmental, Social and Governance Goals, Including Climate Pledge…
PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease
Grant of US patent strengthens the PharmaTher’s intellectual property portfolio covering novel uses and delivery…
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
– atai has dosed the first subject in their Phase 1 single-ascending dose (SAD) trial…
Broken Coast Ranks #1 at the Budtender’s Association Collectors Cup
TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq:…
Eliem Therapeutics Provides Update on Pipeline Progress
Company is positioned to initiate Phase 2a trial in major depressive disorder (MDD) in the…
BioXcel Therapeutics to Host IGALMI™ Commercial Day on October 18, 2022
NEW HAVEN, Conn., Oct. 05, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Plus Therapeutics Announces Patient Webinar in Recognition of Breast Cancer Awareness Month
Principal Investigator Dr. Andrew Brenner to Lead Musella Foundation Live Webinar AUSTIN, Texas, Oct. 05,…
Nubeva Announces Successful Decryption of Ragnar Locker Ransomware for Billion-Dollar Company
Adds this success to its portfolio of successful retrievals following attacks by LockBit, Hive, REvil,…
Fluent Launches Purpose to Empower Consumer Financial Decisions
Company Hires Industry Veteran to Further Consumer Value with Financial Wellness App NEW YORK, Oct. 05,…
Vaadin Releases Acceleration Kits to Speed the Development and Modernization of Enterprise Java Applications
Survey of Java Developers Reveals Vaadin Cuts Development Time and Costs By Nearly Half TURKU,…